Skip to main content
SpringerLink
Log in

PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

To determine the role the multiple drug-resistance (MDR1) gene plays in chronic lymphocytic leukemia (CLL), we measured the expression of the MDR 1 gene in 30 patients with this disease. A rapid, highly sensitive, and nonradioactive technique based on the polymerase chain reaction (PCR) was used for that purpose. In this technique, called differential PCR, the target (MDR 1) and a reference gene (β2-microglobulin) are co-amplified by PCR from random hexamer-primed cDNA in the same reaction vessel. The level of target gene expression is reflected in the ratio between the intensities of the two resulting PCR product bands, as measured by high-performance liquid chromatography (HPLC). MDR 1 gene expression was detectable in 29/30 (97%) patients with CLL, with a median expression level of 0.36 U (human placenta=1 U). There was no correlation between expression of the MDR 1 gene and clinical stage, time from diagnosis, absolute lymphocyte count, several lymphocyte surface markers, or prior treatment in the patients analyzed. Immunocytochemical studies of the same material using the monoclonal antibody C219 showed a very low or undetectable expression of the P-glycoprotein in the lymphocytes of all patients studied, whereas granulocytes were significantly more immunoreactive. We conclude that the level of expression of the MDR 1 gene in CLL is generally low, that the removal of granulocytes is important in studies of expression of MDR 1 mRNA in CLL, and that differential PCR provides a rapid and reliable method for quantifying the amount of a specific mRNA, even in very small samples of total RNA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baas F, Jongsma AP, Broxterman HJ, Arceci RJ, Housman D, Scheffer GL, Riethorst A, van Groeningen M, Nieuwint AW, Joenje H (1990) Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res 50: 5392–5398

    PubMed  Google Scholar 

  2. Broxterman HJ, Pinedo HM, Kuiper CM, et al. (1989) Immunohistochemical detection of P-glycoprotein in human tumour cells with a low degree of drug resistance. Int J Cancer 43: 340–343

    PubMed  Google Scholar 

  3. Callen DF, Baker E, Simmers RN, Seshadri R, Roninson IB (1987) Localization of the human multidrug resistance gene, mdr 1, to 7q21.1. Hum Genet 77: 142–144

    PubMed  Google Scholar 

  4. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D (1992) Clinical significance of multidrug resistance-P-glycoprotein (P-170) expression on acute nonnymphoblastic leukemia cells at diagnosis. Blood 79: 473

    PubMed  Google Scholar 

  5. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in the mdr 1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381–389

    PubMed  Google Scholar 

  6. Deuchars KL, Ling V (1989) P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin Oncol 16: 156–165

    PubMed  Google Scholar 

  7. Epstein J, Xiao H, Oba BK (1989) P-glycoprotein expression in plasma cell myeloma is associated with resistance to VAD. Blood 74: 913–917

    PubMed  Google Scholar 

  8. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Prac Natl Acad Sci USA 84: 265–269

    Google Scholar 

  9. Gerlach JH, Endicott JA, Juranka PF, Henderson G, Sarangi F, Deuchars KL, Ling V (1986) Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324: 485–489

    PubMed  Google Scholar 

  10. Goldstein LJ, Galski H, Fojo A, et al. (1989) Expression of a multidrug-resistance gene in human cancers. J Natl Cancer Inst 81: 116–124

    PubMed  Google Scholar 

  11. Gros P, Croop J, Housman D (1986) Mammalian multidrug-resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371–380

    PubMed  Google Scholar 

  12. Haber DA (1992) Multidrug resistance (MDR 1) in leukemia: is it time to test? Blood 79: 295–298

    PubMed  Google Scholar 

  13. Herweijer H, Sonneveld P, Baas F, Nooter K (1990) Expression of mdr 1 and mdr 3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 82:1133–1140

    PubMed  Google Scholar 

  14. Holmes J, Jacobs A, Carter G, Janowska-Wieczorek A, Padua RA (1989) Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia. Br J Haematol 72: 40–44

    PubMed  Google Scholar 

  15. Holmes JA, Jacobs A, Carter G, Whittaker JA, Bentley DP, Padua RA (1990) Is the mdr 1 gene relevant in chronic lymhocytic leukemia? Leukemia 4: 216–218

    PubMed  Google Scholar 

  16. Ito Y, Tanimoto M, Kumazawa T, Okumura M, Morishima Y, Ohno R, Saito H (1989) Increased P-glycoprotein expression and multidrug-resistant gene (mdr 1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage. Cancer 63: 1534–1538

    PubMed  Google Scholar 

  17. Katz ED, Dong MW (1990) Rapid analysis and purification of polymerase chain reaction products by high-performance liquid chromatography. Biotechniques 8: 546–555

    PubMed  Google Scholar 

  18. Kuwazuru Y, Yoshimura A, Hanada S, Ichikawa M, Saito T, Uozumi K, Utsunomiya A, Arima T, Akiyama S (1990) Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukemia cells in blast crisis. Br J Haematol 74: 24–29

    PubMed  Google Scholar 

  19. Marie JP, Zittoun R, Sikic BI (1991) Multidrug resistance (mdr 1) gene expression in adult leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 78: 586–592

    PubMed  Google Scholar 

  20. Michieli M, Raspadori D, Damiani D, Geromin A, Gallizia C, Michelutti A, Fanin R, Fasola G, Russo D, Tazzari P, et al. (1991) The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia. Br J Haematol 77: 460–465

    PubMed  Google Scholar 

  21. Musto P, Melillo L, Lombardi G, Matera R, di Giorgio G, Carotenuto M (1991) High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein-positive cells in complete remission. Br J Haematol 77: 50–53

    PubMed  Google Scholar 

  22. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB (1990) Quantitative analysis of MDR 1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160–7164

    Google Scholar 

  23. Nooter K, Sonneveld P, Oostrum R, Herweijer H, Hagenbeek T, Valerio D (1990) Overexpression of the mdr 1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A. Int J Cancer 45: 263–268

    PubMed  Google Scholar 

  24. Pirker R, Wallner J, Geissler K, et al. (1991) MDR 1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 83: 708–712

    PubMed  Google Scholar 

  25. Riordan JR, Duechars K, Kartner N (1985) Amplification of p-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316: 817–819

    PubMed  Google Scholar 

  26. Rochlitz CF, Lobeck H, de Kant E, Mohr B, Reuter J, Peter S, Huhn D, Herrmann R (1992) MDR gene expression in human renal cell cancer is associated with the histological subtype. Cancer 69: 2993–2998

    PubMed  Google Scholar 

  27. Rothenberg ML, Mickley LA, Cole DE, Balis FM, Tsuruo T, Poplack DG, Fojo AT (1989) Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. Blood 74: 1388–1395

    PubMed  Google Scholar 

  28. Sato H, Gottesman MM, Goldstein LJ, Pastan I, Block AM, Sandberg AA, Preisler HD (1990) Expression of the multidrug-resistance gene in myeloid leukemias. Leuk Res 14: 11–21

    PubMed  Google Scholar 

  29. Shustik C, Groulx N, Gros P (1991) Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphocytic leukemia (CLL). Br J Haematol 79: 50–56

    PubMed  Google Scholar 

  30. Sonneveld P, Nooter K (1990) Reversal of drug resistance by cyclosporin-A in a patient with acute myelocytic leukaemia. Br J Haematol 75: 208–211

    PubMed  Google Scholar 

  31. Sonneveld P, Nooter K, Burghouts JT, Herweijer H, Adriaansen HJ, van Dongen JJ (1992) High expression of the mdr 3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia. Blood 79: 1496–1500

    PubMed  Google Scholar 

  32. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735–7738

    PubMed  Google Scholar 

  33. Weide R, Dowding C, Paulsen W, Goldman J (1990) The role of the MDR-1/P-170 mechanism in the development of multi-drug resistance in chronic myeloid leukemia. Leukemia 4: 695–699

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Hämatologie/Onkologie, Klinikum Rudolf Virchow der Freien Universität, Spandauer Damm 130, 1000, Berlin 19, Federal Republic of Germany

    C. F. Rochlitz, E. de Kant, A. Neubauer, I. Heide, R. Böhmer, J. Oertel, D. Huhn & R. Herrmann

Authors
  1. C. F. Rochlitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. de Kant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Neubauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Heide
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Böhmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Oertel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Huhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rochlitz, C.F., de Kant, E., Neubauer, A. et al. PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia. Ann Hematol 65, 241–246 (1992). https://doi.org/10.1007/BF01836067

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01836067

Key words

Search

Navigation